Director, Healthcare Provider Promotion Marketing at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Passion for making a difference in HIV therapy and healthcare innovation
Ability to thrive in dynamic environments
Experience in HCP marketing, particularly for launch brands (implied by role demands)

Responsibilities

Support development of HCP personal promotion strategy and executional plan for BIC/LEN in the U.S., ensuring alignment with brand objectives and evolving market dynamics
Lead development of materials and messaging for HCP personal promotion, including call flows, objection handling, and sales tools tailored to a launch brand
Drive strategic planning and execution for HCP engagement for a launch product
Develop marketing solutions to a wide range of complex problems which require the regular use of ingenuity and innovation, ensuring solutions are compliant and consistent with organization objectives
Lead market research projects in close collaboration with cross-functional partners
Adapt and evolve global assets to meet U.S. HCP needs, including messaging and campaign refinement
Develop and refresh HCP promotional campaigns, ensuring relevance and resonance with HCPs
Generate and synthesize insights from multiple data sources to inform strategic decisions and optimize promotional impact
Define and track marketing KPIs, using data to drive continuous improvement and performance optimization
Contribute to HIV portfolio strategy, providing insights and recommendations on go-to-market approaches and cross-brand synergies
Manage agency relationships and budgets, ensuring high-quality output and fiscal discipline
Collaborate cross-functionally with Regulatory, Legal, Medical Affairs, CL&D, II&D, Global Marketing, and Sales Leadership to ensure coordinated execution
Collaborate with Global Partners to adapt and evolve assets and strategy to US HCP needs
Evaluate and evolve marketing systems and processes to support operational excellence and scalability
Deliver compelling presentations to internal stakeholders and external audiences, translating strategy into action
Ensure compliance with all relevant laws, regulations, and industry standards

Skills

Healthcare Provider Marketing

HIV Therapy Marketing

Product Launch

Marketing Strategy

Campaign Development

Clinical Data Interpretation

HCP Education

Field Sales Collaboration

Market Insights

Pharmaceutical Marketing

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free